Cerro Pacific Wealth Advisors’s Zimmer Biomet ZBH Stock Holding History

Cerro Pacific Wealth Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,281	Closed	-$528K	–	123
2021 Q4	$528K	Buy	4,281 +240	+6%	+$31.4K	0.33%	86
2021 Q3	$574K	Buy	4,041 +1,538	+61%	+$226K	0.41%	80
2021 Q2	$391K	Buy	+2,503	New	+$405K	0.29%	97

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cerro Pacific Wealth Advisors's ZBH Position: Q1 2022 in Review

Cerro Pacific Wealth Advisors sold out of Zimmer Biomet (ZBH) in Q1 2022, closing a stake of 4,281 shares — an estimated $528K sold.

Cerro Pacific Wealth Advisors first reported a position in ZBH in Q2 2021 and held it in 3 quarters. The position peaked at $574K in Q3 2021. 977 funds tracked by Wall St. Rank hold ZBH as of Q1 2022.

Cerro Pacific Wealth Advisors reported no remaining Zimmer Biomet position as of Q1 2022 after selling out during the quarter.
Cerro Pacific Wealth Advisors sold 4,281 Zimmer Biomet shares in Q1 2022, an estimated $528K.
Cerro Pacific Wealth Advisors first reported a position in Zimmer Biomet in Q2 2021 and held it in 3 quarters.
Cerro Pacific Wealth Advisors's Zimmer Biomet position peaked at $574K in Q3 2021.
977 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2022.

Based on Cerro Pacific Wealth Advisors's 13F filing for Q1 2022, filed 13 Apr 2022.